Genome-wide DNA methylation profiling of non-small cell lung carcinomas

Epigenetics and Chromatin

Volumn 5, Issue 1, 2012, Pages

  Carvalho, Rejane Hughes ^a   Haberle, Vanja ^b   Hou, Jun ^a   Van Gent, Teus ^a   Thongjuea, Supat ^b   Van Ijcken, Wilfred ^a   Kockx, Christel ^a   Brouwer, Rutger ^a   Rijkers, Erikjan ^a   Sieuwerts, Anieta ^a   Foekens, John ^a   Van Vroonhoven, Mirjam ^a   Aerts, Joachim ^a   Grosveld, Frank ^a   Lenhard, Boris ^b   Philipsen, Sjaak ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

DNA Methylation; Epigenetics; MethylCap; Next generation sequencing; Non small cell lung Cancer

Indexed keywords

BISULFITE; MICROSATELLITE DNA;

ADENOCARCINOMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC CORRELATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 84864753104     PISSN: None     EISSN: 17568935     Source Type: Journal    
DOI: 10.1186/1756-8935-5-9     Document Type: Article

References (55)

1. Cancer statistics, 2010. Jemal A, Siegel R, Xu J, Ward E, CA Cancer J Clin 2010 60 277 300
2. No nodes is good nodes. Little AG, Ann Thorac Surg 2006 82 4 5
3. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA, Mayo Clin Proc 2008 83 584 594 (Pubitemid 351720831)
4. Gene expression-based classification of non-small cell lung carcinomas and survival prediction. Hou J, Aerts J, den Hamer B, van Ijcken W, den Bakker M, Riegman P, van der Leest C, van der Spek P, Foekens JA, Hoogsteden HC, Grosveld F, Philipsen S, et al. PLoS One 2010 5 10312
5. Expression profiling defines a recurrence signature in lung squamous cell carcinoma. Larsen JE, Pavey SJ, Passmore LH, Bowman R, Clarke BE, Hayward NK, Fong KM, Carcinogenesis 2007 28 760 766 (Pubitemid 46523374)
6. Analysing differential gene expression in cancer. Liang P, Pardee AB, Nat Rev Cancer 2003 3 869 876 (Pubitemid 37376983)
7. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients. Kameyama K, Huang CL, Liu D, Masuya D, Nakashima T, Sumitomo S, Takami Y, Kinoshita M, Yokomise H, Clin Cancer Res 2003 9 4926 4934 (Pubitemid 37323299)
8. Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application. Petty RD, Nicolson MC, Kerr KM, Collie-Duguid E, Murray GI, Clin Cancer Res 2004 10 3237 3248 (Pubitemid 38685427)
9. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Ding L, Mardis ER, Li S, Larson DE, Chen K, Wallis JW, Harris CC, McLellan MD, Fulton RS, Fulton LL, Abbott RM, Hoog J, Dooling DJ, Koboldt DC, Schmidt H, Kalicki J, Zhang Q, Chen L, Lin L, Wendl MC, McMichael JF, Magrini VJ, Cook L, McGrath SD, Vickery TL, Appelbaum E, Deschryver K, Davies S, Guintoli T, Lin L, et al. Nature 2010 464 999 1005
10. Human DNA methylomes at base resolution show widespread epigenomic differences. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, Edsall L, Antosiewicz-Bourget J, Stewart R, Ruotti V, Millar AH, Thomson JA, Ren B, Ecker JR, Nature 2009 462 315 322
11. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D, Nat Genet 2005 37 853 862 (Pubitemid 41077111)
12. DNA methylation patterns and epigenetic memory. Bird A, Genes Dev 2002 16 6 21 (Pubitemid 34049633)
13. Methylation-induced repression-belts, braces, and chromatin. Bird AP, Wolffe AP, Cell 1999 99 451 454 (Pubitemid 129746827)
14. A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Leonhardt H, Page AW, Weier HU, Bestor TH, Cell 1992 71 865 873
15. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER, Latif F, Oncogene 2001 20 1509 1518 (Pubitemid 32291201)
16. Promoter methylation of the mutated in colorectal cancer gene is a frequent early event in colorectal cancer. Kohonen-Corish MR, Sigglekow ND, Susanto J, Chapuis PH, Bokey EL, Dent OF, Chan C, Lin BP, Seng TJ, Laird PW, Young J, Leggett BA, Jass JR, Sutherland RL, Oncogene 2007 26 4435 4441 (Pubitemid 47014456)
17. Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis. Liu L, Broaddus RR, Yao JC, Xie S, White JA, Wu TT, Hamilton SR, Rashid A, Mod Pathol 2005 18 1632 1640 (Pubitemid 41670664)
18. Methylation of the RASSF1A gene in human cancers. Pfeifer GP, Yoon JH, Liu L, Tommasi S, Wilczynski SP, Dammann R, Biol Chem 2002 383 907 914 (Pubitemid 34874094)
19. DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients. Feng Q, Hawes SE, Stern JE, Wiens L, Lu H, Dong ZM, Jordan CD, Kiviat NB, Vesselle H, Cancer Epidemiol Biomarkers Prev 2008 17 645 654 (Pubitemid 351469215)
20. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma. Hsu HS, Chen TP, Hung CH, Wen CK, Lin RK, Lee HC, Wang YC, Cancer 2007 110 2019 2026
21. Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Vaissiere T, Hung RJ, Zaridze D, Moukeria A, Cuenin C, Fasolo V, Ferro G, Paliwal A, Hainaut P, Brennan P, Tost J, Boffetta P, Herceg Z, Cancer Res 2009 69 243 252
22. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP, Nat Genet 2000 25 315 319 (Pubitemid 30437320)
23. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis. Clark SJ, Hum Mol Genet 2007 16 Spec No 1 88 R95
24. Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease. Mayor R, Casadome L, Azuara D, Moreno V, Clark SJ, Capella G, Peinado MA, Br J Cancer 2009 100 1534 1539
25. Whole-genome DNA methylation profiling using MethylCap-seq. Brinkman AB, Simmer F, Ma K, Kaan A, Zhu J, Stunnenberg HG, Methods 2010 52 232 236
26. CpG island methylator phenotype (CIMP) in cancer: causes and implications. Teodoridis JM, Hardie C, Brown R, Cancer Lett 2008 268 177 186
27. Evidence for an instructive mechanism of de novo methylation in cancer cells. Keshet I, Schlesinger Y, Farkash S, Rand E, Hecht M, Segal E, Pikarski E, Young RA, Niveleau A, Cedar H, Simon I, Nat Genet 2006 38 149 153 (Pubitemid 43177227)
28. DNA methylation profiling using the methylated-CpG island recovery assay (MIRA). Rauch TA, Pfeifer GP, Methods 2010 52 213 217
29. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Rauch T, Wang Z, Zhang X, Zhong X, Wu X, Lau SK, Kernstine KH, Riggs AD, Pfeifer GP, Proc Natl Acad Sci U S A 2007 104 5527 5532 (Pubitemid 47175714)
30. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Rauch TA, Zhong X, Wu X, Wang M, Kernstine KH, Wang Z, Riggs AD, Pfeifer GP, Proc Natl Acad Sci U S A 2008 105 252 257
31. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates. Schmidt B, Liebenberg V, Dietrich D, Schlegel T, Kneip C, Seegebarth A, Flemming N, Seemann S, Distler J, Lewin J, Tetzner R, Weickmann S, Wille U, Liloglou T, Raji O, Walshaw M, Fleischhacker M, Witt C, Field JK, BMC Cancer 2010 10 600
32. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD, Cancer Res 2001 61 249 255 (Pubitemid 32095725)
33. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB, Proc Natl Acad Sci U S A 1996 93 9821 9826 (Pubitemid 26296693)
34. High-throughput DNA methylation profiling using universal bead arrays. Bibikova M, Lin Z, Zhou L, Chudin E, Garcia EW, Wu B, Doucet D, Thomas NJ, Wang Y, Vollmer E, Goldmann T, Seifart C, Jiang W, Barker DL, Chee MS, Floros J, Fan JB, Genome Res 2006 16 383 393 (Pubitemid 43327509)
35. A second-generation profiling system for quantitative methylation analysis of multiple gene promoters: application to lung cancer. Sano A, Kage H, Sugimoto K, Kitagawa H, Aki N, Goto A, Fukayama M, Nakajima J, Takamoto S, Nagase T, Yatomi Y, Ohishi N, Takai D, Oncogene 2007 26 6518 6525 (Pubitemid 47530604)
36. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. Shames DS, Girard L, Gao B, Sato M, Lewis CM, Shivapurkar N, Jiang A, Perou CM, Kim YH, Pollack JR, Fong KM, Lam CL, Wong M, Shyr Y, Nanda R, Olopade OI, Gerald W, Euhus DM, Shay JW, Gazdar AF, Minna JD, PLoS Med 2006 3 486
37. Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer. Zhang Y, Wang R, Song H, Huang G, Yi J, Zheng Y, Wang J, Chen L, Cancer Letters 2011 303 21 28
38. Genome-wide analysis of DNA methylation and the gene expression change in lung cancer. Kwon YJ, Lee SJ, Koh JS, Kim SH, Lee HW, Kang MC, Bae JB, Kim YJ, Park JH, J Thorac Oncol 2012 7 20 33
39. Computational analysis of genome-wide DNA methylation during the differentiation of human embryonic stem cells along the endodermal lineage. Chavez L, Jozefczuk J, Grimm C, Dietrich J, Timmermann B, Lehrach H, Herwig R, Adjaye J, Genome Res 2010 20 1441 1450
40. DNA methylation profile during multistage progression of pulmonary adenocarcinomas. Chung JH, Lee HJ, Kim BH, Cho NY, Kang GH, Virchows Arch 2011 459 201 211
41. Epigenetic gene silencing in cancer: the DNA hypermethylome. Esteller M, Hum Mol Genet 2007 16 Spec No 1 50 R59
42. Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas. Liu Y, Pang JC, Dong S, Mao B, Poon WS, Ng HK, Hum Pathol 2005 36 416 425 (Pubitemid 40591813)
43. Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors. Marsit CJ, Houseman EA, Christensen BC, Eddy K, Bueno R, Sugarbaker DJ, Nelson HH, Karagas MR, Kelsey KT, Cancer Res 2006 66 10621 10629 (Pubitemid 44799786)
44. Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Ting DT, Lipson D, Paul S, Brannigan BW, Akhavanfard S, Coffman EJ, Contino G, Deshpande V, Iafrate AJ, Letovsky S, Rivera MN, Bardeesy N, Maheswaran S, Haber DA, Science 2011 331 593 596
45. DNA methylation patterns in lung carcinomas. Pfeifer GP, Rauch TA, Semin Cancer Biol 2009 19 181 187
46. Expression profiling-based subtyping identifies novel non-small cell lung cancer subgroups and implicates putative resistance to pemetrexed therapy. Hou J, Lambers M, den Hamer B, den Bakker M, Hoogsteden MC, Grosveld F, Hegmans J, Aerts J, Philipsen S, J Thorac Oncol 2012 7 105 114
47. A role for methyl-CpG binding domain protein 2 in the modulation of the estrogen response of pS2/TFF1 gene. Chatagnon A, Ballestar E, Esteller M, Dante R, PLoS One 2010 5 9665
48. Recruitment of MBD1 to target genes requires sequence-specific interaction of the MBD domain with methylated DNA. Clouaire T, de Las Heras JI, Merusi C, Stancheva I, Nucleic Acids Res 2010 38 4620 4634
49. DNA hypermethylation in lung cancer is targeted at differentiation- associated genes. Helman E, Naxerova K, Kohane IS, Oncogene 2011 31 1181 1188
50. Statistical significance of quantitative PCR. Karlen Y, McNair A, Perseguers S, Mazza C, Mermod N, BMC Bioinformatics 2007 8 131
51. R Development Core Team, R: A language and environment for statistical computing. Reference index version: 2.11.1 R Foundation for Statistical Computing, Vienna, Austria 2010 http://www.R-project.org
52. Bioconductor: open software development for computational biology and bioinformatics. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al. Genome Biol 2004 5 80
53. The human genome browser at UCSC. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D, Genome Res 2002 12 996 1006 (Pubitemid 34662293)
54. A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Down TA, Rakyan VK, Turner DJ, Flicek P, Li H, Kulesha E, Graf S, Johnson N, Herrero J, Tomazou EM, Thorne NP, Bäckdahl L, Herberth M, Howe KL, Jackson DK, Miretti MM, Marioni JC, Birney E, Hubbard TJ, Durbin R, Tavaré S, Beck S, Nat Biotechnol 2008 26 779 785 (Pubitemid 351961453)
55. MEDME: an experimental and analytical methodology for the estimation of DNA methylation levels based on microarray derived MeDIP-enrichment. Pelizzola M, Koga Y, Urban AE, Krauthammer M, Weissman S, Halaban R, Molinaro AM, Genome Res 2008 18 1652 1659